Alkem Laboratories Limited
ALKEM
Kedudukan dalam Saham
#2816
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Harga Saham
$55.19
Modal Pasaran
$6.60B
Perubahan (1 hari)
-0.06%
Perubahan (1 tahun)
-12.43%
Negara
IN
Perdagangan Alkem Laboratories Limited (ALKEM)
Kategori
Healthcare
Nisbah P/B bagi Alkem Laboratories Limited (ALKEM)
Nisbah P/B pada October 2026 TTM: 4.31
Menurut laporan kewangan dan harga saham terkini Alkem Laboratories Limited, nisbah P/B semasa (TTM) ialah 4.31. Pada akhir 2024, nisbah P/B syarikat ialah 5.81.
Sejarah nisbah P/B untuk Alkem Laboratories Limited dari 2010 hingga 2026
Nisbah P/B pada akhir setiap tahun
| Tahun | Nisbah P/B | Ubah |
|---|---|---|
| 2026 (TTM) | 4.31 | -10.49% |
| 2025 | 4.82 | -16.94% |
| 2024 | 5.81 | 29.38% |
| 2023 | 4.49 | -10.43% |
| 2022 | 5.01 | 11.63% |
| 2021 | 4.49 | -0.54% |
| 2020 | 4.51 | 17.52% |
| 2019 | 3.84 | -18.59% |
| 2018 | 4.72 | -20.04% |
| 2017 | 5.90 | 34.33% |
| 2016 | 4.39 | -20.25% |
| 2015 | 5.51 | -11.47% |
| 2014 | 6.22 | -10.59% |
| 2013 | 6.96 | -19.73% |
| 2012 | 8.67 | -25.08% |
| 2011 | 11.57 | -15.57% |
| 2010 | 13.71 | 0.00% |
Nisbah P/B untuk syarikat atau pesaing yang serupa
| Syarikat | Nisbah P/B | Perbezaan Nisbah P/B | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 16.85% |
IN
|
